Last reviewed · How we verify
NCT04295928: GREPH
Establishment of a Personalized Pharmaceutical Plan in Renal or Hepatic Transplant Patients
NA trial testing PPP in Personalized Pharmaceutical Plan After Transpantation in 1,716 participants. Status unknown.
11 September 2022
Quick facts
| Lead sponsor | University Hospital, Tours |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 1,716 |
| Start date | 12 October 2020 |
| Primary completion | 11 September 2022 |
| Estimated completion | 11 September 2025 |
| Sites | 12 locations across France |
Drugs / interventions tested
- PPP — full drug profile →
Conditions studied
- Personalized Pharmaceutical Plan After Transpantation — all drugs for Personalized Pharmaceutical Plan After Transpantation →
Sponsor
University Hospital, Tours
Who can join
18 and older, any sex, with Personalized Pharmaceutical Plan After Transpantation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective of the study is to evaluate the impact of the Personalized Pharmaceutical Plan on the therapeutic adherence to immunosuppressive treatments one year after liver or kidney transplantation.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Implementing a personalized pharmaceutical plan in kidney or liver transplant patients: study protocol for a stepped-wedge cluster randomized trial (GRePH).
Pourrat X, Berthy E, Dupuis A, Barbier L, et al · · 2021 · cited 2× · PMID 34749777 · DOI 10.1186/s13063-021-05749-w
Verify or expand the search:
- PubMed search for NCT04295928
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of PPP
Trials testing the same drug.
- NCT04995237 — RHWP Prescription Produce Plan · NA · completed
- NCT04502875 — Clinical Trial to Evaluate the Efficacy of Intracavernosal Infusion of PRP vs PPP for the Erectile Dysfunction. · Phase 2 · unknown
Other University Hospital, Tours trials
Trials by the same sponsor.
- NCT07452978 — Propranolol for Early Secondary Prevention of Post-Traumatic Stress Disorder in Women Victims of Sexual Violence · Phase 2 · not yet recruiting
- NCT07443800 — Comorbidity Between Attention Deficit Hyperactivity Disorder and Fibromyalgia · NA · not yet recruiting
- NCT07251530 — Communication Enhancement Among Ventilated Patients in Intensive Care · not yet recruiting
- NCT07189338 — Apneic Oxygenation With High-flow Nasal Oxygenation After Preoxygenation With Noninvasive Ventilation Before Intubation · NA · not yet recruiting
- NCT07054112 — Efficacy of Live Online Course Mindfulness Program on Perceived Fatigue in Hemodialysis Patients · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04295928 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Tours
- Last refreshed: 3 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04295928.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing